Ignite Creation Date:
2024-05-06 @ 4:26 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04989322
Status:
RECRUITING
Last Update Posted:
2021-12-08
First Post:
2021-07-26
Brief Title:
Pembrolizumab Lenvatinib and Chemotherapy After TKIs in NSCLC
Sponsor:
Dr Joanne CHIU
Organization:
The University of Hong Kong
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-26
First Submit QC Date:
August 3 2021
Study First Post Date:
2021-08-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-25
Last Update Post Date:
2021-12-08
Last Update Post Date Type:
ACTUAL